Screener
Ovid Therapeutics OVID Q1 2025 Annual earnings
Reported May 13, 2025 · Before market open
Revenue$130.0KBeat by $87.5K
EPS-$0.14In line
Revenue estimate$42.5K
EPS estimate-$0.14
Next report
Nov 11, 2026 (In 1 week)Revenue estimate$31.1K
EPS estimate-$0.08
Versus estimates
Revenue
Q2 2026$733.0KBeat by $711.6KQ4 2025$718.0KBeat by $639.8KQ3 2025$132.0KBeat by $69.4KQ2 2025$6.3MBeat by $6.2M
Q1 2025$130.0KBeat by $87.5K
Diluted EPS
FAQ
- When did Ovid Therapeutics report Q1 2025 earnings?
- Ovid Therapeutics (OVID) reported Q1 2025 earnings on May 13, 2025 before market open.
- What were Ovid Therapeutics's Q1 2025 revenue and EPS?
- Ovid Therapeutics reported revenue of $130.0K and eps of $-0.14 for Q1 2025.
- Did Ovid Therapeutics beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $42.5K by $87.5K. EPS beat the consensus estimate of $-0.14 by $0.00.
- How did Ovid Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 12.2% from $148.0K a year earlier and eps grew 17.6% from $-0.17.
- Where can I find Ovid Therapeutics's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001628280-25-024911) and the 10-K/A periodic report (0001628280-25-021055) directly on SEC EDGAR. The filing index links above go to sec.gov.
